IRIS Accounts Production v24.2.0.383 07932878 Board of Directors 1.1.23 31.12.23 31.12.23 false true false false false true true false Ordinary 1.00000 162531 221735 258531 181266 96000 203000 162531 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh079328782022-12-31079328782023-12-31079328782023-01-012023-12-31079328782021-12-31079328782022-01-012022-12-31079328782022-12-3107932878ns15:EnglandWales2023-01-012023-12-3107932878ns14:PoundSterling2023-01-012023-12-3107932878ns10:Director12023-01-012023-12-3107932878ns10:PrivateLimitedCompanyLtd2023-01-012023-12-3107932878ns10:SmallEntities2023-01-012023-12-3107932878ns10:AuditExempt-NoAccountantsReport2023-01-012023-12-3107932878ns10:SmallCompaniesRegimeForDirectorsReport2023-01-012023-12-3107932878ns10:SmallCompaniesRegimeForAccounts2023-01-012023-12-3107932878ns10:FullAccounts2023-01-012023-12-310793287812023-01-012023-12-3107932878ns10:OrdinaryShareClass12023-01-012023-12-310793287842ns10:Director22022-12-310793287842ns10:Director22023-01-012023-12-310793287842ns10:Director22022-01-012022-12-310793287842ns10:Director22023-12-310793287842ns10:Director22022-12-3107932878ns10:Director22023-01-012023-12-3107932878ns10:RegisteredOffice2023-01-012023-12-3107932878ns5:CurrentFinancialInstruments2023-12-3107932878ns5:CurrentFinancialInstruments2022-12-3107932878ns5:ShareCapital2023-12-3107932878ns5:ShareCapital2022-12-3107932878ns5:RetainedEarningsAccumulatedLosses2023-12-3107932878ns5:RetainedEarningsAccumulatedLosses2022-12-310793287812023-01-012023-12-3107932878ns5:IntangibleAssetsOtherThanGoodwill2023-01-012023-12-3107932878ns5:ComputerSoftware2023-01-012023-12-3107932878ns5:IntangibleAssetsOtherThanGoodwill2022-12-3107932878ns5:IntangibleAssetsOtherThanGoodwill2023-12-3107932878ns5:IntangibleAssetsOtherThanGoodwill2022-12-3107932878ns5:ShortLeaseholdAssetsns5:LandBuildings2022-12-3107932878ns5:PlantMachinery2022-12-3107932878ns5:FurnitureFittings2022-12-3107932878ns5:ShortLeaseholdAssetsns5:LandBuildings2023-01-012023-12-3107932878ns5:PlantMachinery2023-01-012023-12-3107932878ns5:FurnitureFittings2023-01-012023-12-3107932878ns5:ShortLeaseholdAssetsns5:LandBuildings2023-12-3107932878ns5:PlantMachinery2023-12-3107932878ns5:FurnitureFittings2023-12-3107932878ns5:ShortLeaseholdAssetsns5:LandBuildings2022-12-3107932878ns5:PlantMachinery2022-12-3107932878ns5:FurnitureFittings2022-12-3107932878ns5:MotorVehicles2022-12-3107932878ns5:ComputerEquipment2022-12-3107932878ns5:MotorVehicles2023-01-012023-12-3107932878ns5:ComputerEquipment2023-01-012023-12-3107932878ns5:MotorVehicles2023-12-3107932878ns5:ComputerEquipment2023-12-3107932878ns5:MotorVehicles2022-12-3107932878ns5:ComputerEquipment2022-12-3107932878ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-12-3107932878ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-12-3107932878ns5:DeferredTaxation2022-12-3107932878ns5:DeferredTaxation2023-01-012023-12-3107932878ns5:DeferredTaxation2023-12-3107932878ns10:OrdinaryShareClass12023-12-31079328781ns10:Director12022-12-31079328781ns10:Director12021-12-31079328781ns10:Director12023-01-012023-12-31079328781ns10:Director12022-01-012022-12-31079328781ns10:Director12023-12-31079328781ns10:Director12022-12-31
REGISTERED NUMBER: 07932878 (England and Wales)











FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2023

FOR

4T MEDICAL LTD

4T MEDICAL LTD (REGISTERED NUMBER: 07932878)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


4T MEDICAL LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 31 DECEMBER 2023







DIRECTORS: J T Tordjmann
L R E Tordjmann





REGISTERED OFFICE: Unit 10F Bourn Quarter
Wellington Way
Caldecote
Cambridge
CB23 7FW





REGISTERED NUMBER: 07932878 (England and Wales)





ACCOUNTANTS: Thompson Taraz Rand Ltd
Chartered Accountants
10 Jesus Lane
Cambridge
Cambridgeshire
CB5 8BA

4T MEDICAL LTD (REGISTERED NUMBER: 07932878)

BALANCE SHEET
31 DECEMBER 2023

2023 2022
Notes £    £   
FIXED ASSETS
Intangible assets 5 30,849 37,428
Tangible assets 6 405,715 46,367
436,564 83,795

CURRENT ASSETS
Stocks 707,794 608,974
Debtors 7 475,882 385,455
Cash at bank 2,139,509 1,760,721
3,323,185 2,755,150
CREDITORS
Amounts falling due within one year 8 (711,829 ) (558,342 )
NET CURRENT ASSETS 2,611,356 2,196,808
TOTAL ASSETS LESS CURRENT LIABILITIES 3,047,920 2,280,603

PROVISIONS FOR LIABILITIES 9 (64,499 ) (11,092 )
NET ASSETS 2,983,421 2,269,511

CAPITAL AND RESERVES
Called up share capital 10 2 2
Retained earnings 2,983,419 2,269,509
SHAREHOLDERS' FUNDS 2,983,421 2,269,511

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

4T MEDICAL LTD (REGISTERED NUMBER: 07932878)

BALANCE SHEET - continued
31 DECEMBER 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and loss account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 3 September 2024 and were signed on its behalf by:





J T Tordjmann - Director


4T MEDICAL LTD (REGISTERED NUMBER: 07932878)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023

1. STATUTORY INFORMATION

4T Medical Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

3. ACCOUNTING POLICIES

Basis of preparing the financial statements
The financial statements have been prepared under the historical cost convention.

Critical accounting judgements and key sources of estimation uncertainty
Useful economic lives of tangible fixed assets:
Tangible fixed assets are depreciated over their expected useful lives taking into consideration residual values, where appropriate. The actual lives of the assets and residual values are assessed and amended when necessary to reflect the current estimates based on economic utilisation and physical condition of the assets.

Doubtful debts:
The company makes an estimate of the recoverable value of trade and other debtors. When assessing impairment of trade debtors , management considers factors including the current credit rating of the debtor, the ageing of the debtor and historical experience regarding payment history.

Turnover
Turnover represents the sale of skincare products and is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Revenue is recognised in the profit and loss account when a sales invoice is raised and this occurs on the dispatch of goods.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Computer software is being amortised evenly over its estimated useful life of ten years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Leasehold Improvements 20% on cost
Plant and Machinery25% on cost
Fixtures and Fittings 25% on cost
Motor vehicles25% on cost
Computer equipment25% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

4T MEDICAL LTD (REGISTERED NUMBER: 07932878)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2023

3. ACCOUNTING POLICIES - continued

Financial instruments
Basic financial assets and basic financial liabilities as defined under section 11 of FRS 102, including trade and other debtors, trade and other creditors, cash and bank balances and investments in commercial paper, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and loss account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all material timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

4. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 21 (2022 - 16 ) .

4T MEDICAL LTD (REGISTERED NUMBER: 07932878)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2023

5. INTANGIBLE FIXED ASSETS
Other
intangible
assets
£   
COST
At 1 January 2023
and 31 December 2023 65,791
AMORTISATION
At 1 January 2023 28,363
Charge for year 6,579
At 31 December 2023 34,942
NET BOOK VALUE
At 31 December 2023 30,849
At 31 December 2022 37,428

Other intangible fixed assets relate to computer software.

6. TANGIBLE FIXED ASSETS
Fixtures
Short Plant and and
leasehold machinery fittings
£    £    £   
COST
At 1 January 2023 27,438 9,434 81,286
Additions 358,280 - 19,579
Disposals - - -
At 31 December 2023 385,718 9,434 100,865
DEPRECIATION
At 1 January 2023 25,438 2,555 56,615
Charge for year 1,000 2,359 16,466
Eliminated on disposal - - -
At 31 December 2023 26,438 4,914 73,081
NET BOOK VALUE
At 31 December 2023 359,280 4,520 27,784
At 31 December 2022 2,000 6,879 24,671

4T MEDICAL LTD (REGISTERED NUMBER: 07932878)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2023

6. TANGIBLE FIXED ASSETS - continued

Motor Computer
vehicles equipment Totals
£    £    £   
COST
At 1 January 2023 8,250 52,729 179,137
Additions - 11,973 389,832
Disposals - (3,257 ) (3,257 )
At 31 December 2023 8,250 61,445 565,712
DEPRECIATION
At 1 January 2023 7,391 40,771 132,770
Charge for year 859 9,800 30,484
Eliminated on disposal - (3,257 ) (3,257 )
At 31 December 2023 8,250 47,314 159,997
NET BOOK VALUE
At 31 December 2023 - 14,131 405,715
At 31 December 2022 859 11,958 46,367

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 233,509 201,568
Other debtors 242,373 183,887
475,882 385,455

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade creditors 118,796 82,105
Taxation and social security 481,582 441,442
Other creditors 111,451 34,795
711,829 558,342

9. PROVISIONS FOR LIABILITIES
2023 2022
£    £   
Deferred tax 64,499 11,092

4T MEDICAL LTD (REGISTERED NUMBER: 07932878)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2023

9. PROVISIONS FOR LIABILITIES - continued

Deferred
tax
£   
Balance at 1 January 2023 11,092
Utilised during year 51,311
Effect of rate movement 2,096
Balance at 31 December 2023 64,499

Deferred tax is recognised in respect of the excess of capital allowances over depreciation.

10. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2023 2022
value: £    £   
2 Ordinary £1 2 2

11. OTHER FINANCIAL COMMITMENTS

At the balance sheet date the company had off balance sheet commitments due under non cancellable operating leases amounting to £612,536 (2022: £123,779) in respect of the leasing of commercial units and company vehicles.

12. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 December 2023 and 31 December 2022:

2023 2022
£    £   
J T Tordjmann and L R E Tordjmann
Balance outstanding at start of year 162,531 -
Amounts advanced 221,735 258,531
Amounts repaid (181,266 ) (96,000 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 203,000 162,531

Included within Amounts Advanced is beneficial loan interest charged at 2% of £3,000 (2022 £1,609). It is expected these advances will be repaid in full within nine months of the balance sheet date,

13. RELATED PARTY DISCLOSURES

During the year under review £221,736 (2022: £162,531) was advanced to the directors. These advances are unsecured and repayable on demand. Total advances includes beneficial loan interest charged at 2% of £3,857 (2022:£1,609).The amount outstanding at the balance sheet date is £203,000 (2022: £162,531) and included within other debtors.